FDA Label for Wellmind Vertigo
View Indications, Usage & Precautions
Wellmind Vertigo Product Label
The following document was submitted to the FDA by the labeler of this product Medinatura Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Warnings:
If pregnant or breast-feeding, ask
a health professional before use. Keep out of
reach of children. If symptoms persist or worsen,
a healthcare provider should be consulted. Do not
use if known sensitivity to WellMind Vertigo® or any
of its ingredients exists.
Active Ingredients
Each 300 mg tablet contains:
*Anacardium orientale 6X 10mg, *Cocculus indicus
4X 210mg, *Conium maculatum 3X 30mg,
*Petroleum 8X 20mg, *Selenium metallicum 6X
10mg, *Selenium metallicum 12X 10mg, *Selenium
metallicum 30X 10mg. *Natural
Inactive Ingredients:
*Dextrose, *Lactose,
Magnesium stearate, *Maltodextrin
*contains one or more of these ingredients
Purpose
Motion Sickness
Relief
Directions:
Adults and children 12 years and
older: 1-2 tablets 3 times per day or as directed by a
health practitioner. Not to exceed 6 tablets per 24
hours. Children under 12, as directed by a health
professional. Allow to completely dissolve in the mouth
Keep Out Of Reach Of Children
Keep out of reach of children.
Indications:
For the temporary relief of minor
lightheadedness and motion sickness.
* Please review the disclaimer below.